Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation.

Abstract:

:The flavonoid naringenin improves hyperlipidemia and hyperglycemia in streptozotocin-treated rats. In HepG2 human hepatoma cells, naringenin inhibits apolipoprotein B (apoB) secretion primarily by inhibiting microsomal triglyceride transfer protein and enhances LDL receptor (LDLr)-mediated apoB-containing lipoprotein uptake. Phosphatidylinositol 3-kinase (PI3K) activation by insulin increases sterol regulatory element-binding protein (SREBP)-1 and LDLr expression and inhibits apoB secretion in hepatocytes. Thus, we determined whether naringenin activates this pathway. Insulin and naringenin induced PI3K-dependent increases in cytosolic and nuclear SREBP-1 and LDLr expression. Similar PI3K-mediated increases in SREBP-1 were observed in McA-RH7777 rat hepatoma cells, which express predominantly SREBP-1c. Reductions in HepG2 cell media apoB with naringenin were partially attenuated by wortmannin, whereas the effect of insulin was completely blocked. Both treatments reduced apoB100 secretion in wild-type and LDLr(-/-) mouse hepatocytes to the same extent. Insulin and naringenin increased HepG2 cell PI3K activity and decreased insulin receptor substrate (IRS)-2 levels. In sharp contrast to insulin, naringenin did not induce tyrosine phosphorylation of IRS-1. We conclude that naringenin increases LDLr expression in HepG2 cells via PI3K-mediated upregulation of SREBP-1, independent of IRS-1 phosphorylation. Although this pathway may not regulate apoB secretion in primary hepatocytes, PI3K activation by this novel mechanism may explain the insulin-like effects of naringenin in vivo.

journal_name

Diabetes

journal_title

Diabetes

authors

Borradaile NM,de Dreu LE,Huff MW

doi

10.2337/diabetes.52.10.2554

subject

Has Abstract

pub_date

2003-10-01 00:00:00

pages

2554-61

issue

10

eissn

0012-1797

issn

1939-327X

journal_volume

52

pub_type

杂志文章

相关文献

DIABETES文献大全
  • Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.

    abstract::A number of patients with type 2 diabetes are GAD antibody positive. A Diabetes Outcome Progression Trial (ADOPT) is a randomized, double-blind clinical trial in recently diagnosed drug-naive patients with type 2 diabetes that allows for the evaluation of GAD positivity in the context of anthropometric and biochemical...

    journal_title:Diabetes

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.2337/diabetes.53.12.3193

    authors: Zinman B,Kahn SE,Haffner SM,O'Neill MC,Heise MA,Freed MI,ADOPT Study Group.

    更新日期:2004-12-01 00:00:00

  • Epinephrine enhancement of potassium-stimulated immunoreactive insulin secretion. Role of beta-adrenergic receptors.

    abstract::Although epinephrine stimulates insulin release by activation of beta-adrenergic receptors, its dominant effect (mediated by stimulation of alpha-adrenergic receptors) is an inhibition of insulin secretion that is powerful enough to suppress the secretory activity of insulin's most potent stimulants. The insulin-secre...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.27.5.550

    authors: Hiatt N,Davidson MB,Chapman LW,Sheinkopf JA

    更新日期:1978-05-01 00:00:00

  • Biosynthesis of proinsulin and other islet cell proteins in pancreatic beta cells of the rat: a radioautographic evaluation of glucose effects in vitro.

    abstract::Rat pancreatic islets were incubated in vitro with L-[4,5-3H]leucine or with L-[2,3-3H]tryptophan in Krebs-Ringer bicarbonate buffer, containing 0, 5, or 20 mM glucose. Incorporation of labeled amino acids in islet cells was evaluated quantitatively by a validated radioautographic procedure. Incorporation of labeled l...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diacare.20.10.795

    authors: Logothetopoulos J,Jain K

    更新日期:1980-10-01 00:00:00

  • Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.

    abstract::Patient-derived progenitor cell (PC) dysfunction is severely impaired in diabetes, but the molecular triggers that contribute to mechanisms of PC dysfunction are not fully understood. Methylglyoxal (MGO) is one of the highly reactive dicarbonyl species formed during hyperglycemia. We hypothesized that the MGO scavenge...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db18-0933

    authors: Li H,O'Meara M,Zhang X,Zhang K,Seyoum B,Yi Z,Kaufman RJ,Monks TJ,Wang JM

    更新日期:2019-06-01 00:00:00

  • Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health.

    abstract::Human but not mouse islets transplanted into immunodeficient NSG mice effectively accumulate lipid droplets (LDs). Because chronic lipid exposure is associated with islet β-cell dysfunction, we investigated LD accumulation in the intact human and mouse pancreas over a range of ages and states of diabetes. Very few LDs...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db19-0281

    authors: Tong X,Dai C,Walker JT,Nair GG,Kennedy A,Carr RM,Hebrok M,Powers AC,Stein R

    更新日期:2020-03-01 00:00:00

  • Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.

    abstract:OBJECTIVE:Insulin deficiency in type 1 diabetes and in rodent autoimmune diabetes models is caused by beta-cell-specific killing by autoreactive T-cells. Less is known about beta-cell numbers and phenotype remaining at diabetes onset and the fate of other pancreatic endocrine cellular constituents. RESEARCH DESIGN AND...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db08-0616

    authors: Pechhold K,Zhu X,Harrison VS,Lee J,Chakrabarty S,Koczwara K,Gavrilova O,Harlan DM

    更新日期:2009-05-01 00:00:00

  • Systematic variation and differences in insulin-autoantibody measurements.

    abstract::Insulin autoantibodies (IAAs) are currently the subject of intensive investigation as potential markers for autoimmune insulitis. However, the results of different reports vary widely. In an attempt to elucidate the reasons for the discrepant reports and to initiate standardization procedures, the International Diabet...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.38.2.172

    authors: Wilkin TJ,Schoenfeld SL,Diaz JL,Kruse V,Bonifacio E,Palmer JP

    更新日期:1989-02-01 00:00:00

  • Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics.

    abstract:OBJECTIVE:To examine associations of neonatal adiposity with maternal glucose levels and cord serum C-peptide in a multicenter multinational study, the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study, thereby assessing the Pederson hypothesis linking maternal glycemia and fetal hyperinsulinemia to neonatal adi...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db08-1112

    authors: HAPO Study Cooperative Research Group.

    更新日期:2009-02-01 00:00:00

  • The cell cycle inhibitory protein p21cip is not essential for maintaining beta-cell cycle arrest or beta-cell function in vivo.

    abstract::p21(cip1), a regulatory molecule upstream of the G(1/0) checkpoint, is increased in beta-cells in response to mitogenic stimulation. Whereas p21(cip1) can variably stimulate or inhibit cell cycle progression, in vitro studies suggest that p21(cip1) acts as an inhibitor in the pancreatic beta-cell. To determine the fun...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db06-0627

    authors: Cozar-Castellano I,Haught M,Stewart AF

    更新日期:2006-12-01 00:00:00

  • No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion.

    abstract::A recent study has demonstrated secondary amyloidosis in dogs treated with continuous intravenous insulin infusion. Since elevated levels of serum amyloid A protein (SAA) and diminished amyloid fibril degrading activity (AFDA) are associated with amyloidosis, we measured SAA and AFDA in ten type I diabetics treated wi...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.32.1.88

    authors: Koivisto VA,Teppo AM,Maury CP,Taskinen MR

    更新日期:1983-01-01 00:00:00

  • Antibodies to nucleic acids in juvenile-onset diabetes.

    abstract::Antibodies to single stranded (SS-) and double stranded (DS-) DNA and RNA were determined by a passive microhemagglutination assay in sera from 80 children with juvenile-onset diabetes mellitus (JDM) and 129 children with asthma. The latter group was chosen for comparison with the JDM group because of their increased ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.27.11.1105

    authors: Huang SW,Maclaren NK

    更新日期:1978-11-01 00:00:00

  • Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.

    abstract::GAD autoantibodies (GADAs) are sensitive markers of islet autoimmunity and type 1 diabetes. They form the basis of robust prediction models and are widely used for the recruitment of subjects at high risk of type 1 diabetes to prevention trials. However, GADAs are also found in many individuals at low risk of diabetes...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db14-1693

    authors: Williams AJ,Lampasona V,Schlosser M,Mueller PW,Pittman DL,Winter WE,Akolkar B,Wyatt R,Brigatti C,Krause S,Achenbach P,Participating Laboratories.

    更新日期:2015-09-01 00:00:00

  • Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    abstract:OBJECTIVE:Insulin resistance in skeletal muscle is a major risk factor for type 2 diabetes in women with polycystic ovary syndrome (PCOS). However, the molecular mechanisms underlying skeletal muscle insulin resistance and the insulin-sensitizing effect of thiazolidinediones in PCOS in vivo are less well characterized....

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db07-0706

    authors: Højlund K,Glintborg D,Andersen NR,Birk JB,Treebak JT,Frøsig C,Beck-Nielsen H,Wojtaszewski JF

    更新日期:2008-02-01 00:00:00

  • New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes.

    abstract::We investigated the significance of the variants of the IRS-2 gene in patients with type 2 diabetes. The entire coding part of the IRS-2 gene was screened by single-strand conformation polymorphism analysis in 40 Chinese and 40 Finnish patients with late-onset type 2 diabetes. The association of the variants of the IR...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diabetes.50.8.1949

    authors: Wang H,Rissanen J,Miettinen R,Kärkkäinen P,Kekäläinen P,Kuusisto J,Mykkänen L,Karhapää P,Laakso M

    更新日期:2001-08-01 00:00:00

  • Interleukin-6 Reduces β-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response.

    abstract::Production of reactive oxygen species (ROS) is a key instigator of β-cell dysfunction in diabetes. The pleiotropic cytokine interleukin 6 (IL-6) has previously been linked to β-cell autophagy but has not been studied in the context of β-cell antioxidant response. We used a combination of animal models of diabetes and ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db17-1280

    authors: Marasco MR,Conteh AM,Reissaus CA,Cupit JE 5th,Appleman EM,Mirmira RG,Linnemann AK

    更新日期:2018-08-01 00:00:00

  • Adrenergic mediation of hypoglycemia-associated autonomic failure.

    abstract:OBJECTIVE:We tested the hypothesis that adrenergic activation, cholinergic activation, or both, mediate the effect of recent antecedent hypoglycemia to reduce the sympathoadrenal response to subsequent hypoglycemia, the key feature of hypoglycemia-associated autonomic failure in diabetes, in humans. RESEARCH DESIGN AN...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db10-1374

    authors: Ramanathan R,Cryer PE

    更新日期:2011-02-01 00:00:00

  • Diabetic complications in a patient with coexisting anterior hypopituitarism.

    abstract::We present a patient who developed insulin-requiring diabetes several years after the onset of symptoms of anterior hypopituitarism. It is likely that the hypopituitarism protected him against the development of diabetic retinopathy and glomerular basement membrane thickening but not against neuropathy and atheroma. T...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.24.11.1027

    authors: Greenwood RH,Ireland JT,Jones DH,Mahler RF

    更新日期:1975-11-01 00:00:00

  • Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.

    abstract::To investigate the effects of insulin on platelets in obesity and in non-insulin-dependent diabetes mellitus (NIDDM)--classic insulin-resistant states--we determined ADP-induced platelet aggregation and platelet cGMP (guanosine 3',5'-cyclic monophosphate) content in platelet-rich plasma obtained from nine obese subjec...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.44.11.1318

    authors: Trovati M,Mularoni EM,Burzacca S,Ponziani MC,Massucco P,Mattiello L,Piretto V,Cavalot F,Anfossi G

    更新日期:1995-11-01 00:00:00

  • Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

    abstract::Halofenate has been shown previously to lower triglycerides in dyslipidemic subjects. In addition, significant decreases in fasting plasma glucose were observed but only in type 2 diabetic patients. We hypothesized that halofenate might be an insulin sensitizer, and we present data to suggest that halofenate is a sele...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db06-0618

    authors: Allen T,Zhang F,Moodie SA,Clemens LE,Smith A,Gregoire F,Bell A,Muscat GE,Gustafson TA

    更新日期:2006-09-01 00:00:00

  • Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase.

    abstract::Both pancreatic volume reduction and lipomatosis have been observed in subjects with diabetes. The underlying molecular and pathological mechanisms are, however, poorly known, and it has been speculated that both features are secondary to diabetes. We have recently described pancreatic atrophy and lipomatosis in diabe...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db06-0859

    authors: Raeder H,Haldorsen IS,Ersland L,Grüner R,Taxt T,Søvik O,Molven A,Njølstad PR

    更新日期:2007-02-01 00:00:00

  • A new genetically obese-hyperglycemic rat (Wistar fatty).

    abstract::The fa-gene was transferred from the Zucker rat (13 M strain) to the Wistar Kyoto (WKY) rat. The survey, performed at the 10th generation of backcrossing, showed that Wistar fatty rats (fa/fa), a congenic strain of WKY, developed obesity and obesity-related features, such as hyperinsulinemia and hyperlipemia, in the s...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.30.12.1045

    authors: Ikeda H,Shino A,Matsuo T,Iwatsuka H,Suzuoki Z

    更新日期:1981-12-01 00:00:00

  • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells.

    abstract::IA-2, a member of the protein tyrosine phosphatase family, represents a major target autoantigen in type 1 diabetes. To study the regulation of IA-2 gene expression, we used INS-1 insulinoma cells to analyze beta-cell signal transduction pathways as well as the effect of metabolic and hormonal factors involved in the ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diabetes.49.7.1137

    authors: Seissler J,Nguyen TB,Aust G,Steinbrenner H,Scherbaum WA

    更新日期:2000-07-01 00:00:00

  • Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.

    abstract:OBJECTIVE:To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant recipients. RESEARCH DESIGN AND METHODS:We monitored autoantibodies and autoreactive T-cells (using tetramers) and performed biopsy. The function of auto...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db09-0498

    authors: Vendrame F,Pileggi A,Laughlin E,Allende G,Martin-Pagola A,Molano RD,Diamantopoulos S,Standifer N,Geubtner K,Falk BA,Ichii H,Takahashi H,Snowhite I,Chen Z,Mendez A,Chen L,Sageshima J,Ruiz P,Ciancio G,Ricordi C,Reij

    更新日期:2010-04-01 00:00:00

  • BH3-only molecule Bim mediates β-cell death in IRS2 deficiency.

    abstract::Irs2-deficient mice develop type 2-like diabetes due to a reduction in β-cell mass and a failure of pancreatic islets to undergo compensatory hyperplasia in response to insulin resistance. In order to define the molecular mechanisms, we knocked down Irs2 gene expression in mouse MIN6 insulinoma cells. Insulin receptor...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db13-1814

    authors: Ren D,Sun J,Mao L,Ye H,Polonsky KS

    更新日期:2014-10-01 00:00:00

  • Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes.

    abstract::Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing β-cells in the pancreas. Thereby, the chemokine CXC-motif ligand 10 (CXCL10) plays an important role in the recruitment of autoaggressive lymphocytes to the islets of Langerhans. Transplantation of isolated islets as a promising therapy...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db16-0547

    authors: Bender C,Christen S,Scholich K,Bayer M,Pfeilschifter JM,Hintermann E,Christen U

    更新日期:2017-01-01 00:00:00

  • HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes.

    abstract::Type 1 diabetes studies consistently generate data showing islet β-cell dysfunction and T cell-mediated anti-β-cell-specific autoimmunity. To explore the pathogenesis, we interrogated the β-cell transcriptomes from donors with and without type 1 diabetes using both bulk-sorted and single β-cells. Consistent with immun...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db18-0686

    authors: Russell MA,Redick SD,Blodgett DM,Richardson SJ,Leete P,Krogvold L,Dahl-Jørgensen K,Bottino R,Brissova M,Spaeth JM,Babon JAB,Haliyur R,Powers AC,Yang C,Kent SC,Derr AG,Kucukural A,Garber MG,Morgan NG,Harlan DM

    更新日期:2019-05-01 00:00:00

  • Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants.

    abstract::Large genome-wide association studies of glycemic traits have identified genetics variants that are associated with insulin resistance (IR) in the general population. It is unknown whether people with genetic enrichment for these IR variants respond differently to interventions that aim to improve insulin sensitivity....

    journal_title:Diabetes

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2337/db15-0950

    authors: Hivert MF,Christophi CA,Franks PW,Jablonski KA,Ehrmann DA,Kahn SE,Horton ES,Pollin TI,Mather KJ,Perreault L,Barrett-Connor E,Knowler WC,Florez JC,Diabetes Prevention Program Research Group.

    更新日期:2016-02-01 00:00:00

  • Regulation of hexokinase II gene transcription and glucose phosphorylation by catecholamines, cyclic AMP, and insulin.

    abstract::The hexokinases, by converting glucose to glucose-6-phosphate, help maintain the downhill gradient that results in movement of glucose into cells through the facilitative glucose transporters. GLUT4 and hexokinase (HK) II are the major transporter and hexokinase isoforms in skeletal muscle, heart, and adipose tissue, ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.44.12.1426

    authors: Osawa H,Printz RL,Whitesell RR,Granner DK

    更新日期:1995-12-01 00:00:00

  • Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

    abstract:OBJECTIVE:12/15-lipoxygenase (12/15-LO), one of a family of fatty acid oxidoreductase enzymes, reacts with polyenoic fatty acids to produce proinflammatory lipids. 12/15-LO is expressed in macrophages and pancreatic beta-cells. It enhances interleukin 12 production by macrophages, and several of its products induce apo...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db07-0830

    authors: McDuffie M,Maybee NA,Keller SR,Stevens BK,Garmey JC,Morris MA,Kropf E,Rival C,Ma K,Carter JD,Tersey SA,Nunemaker CS,Nadler JL

    更新日期:2008-01-01 00:00:00

  • Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.

    abstract::Type 2 diabetes (T2D) is associated with vascular dysfunction. We hypothesized that increased nuclear factor-κB (NF-κB) signaling contributes to vascular dysfunction in T2D. We treated type 2 diabetic (db(-)/db(-)) and control (db(-)/db(+)) mice with two NF-κB inhibitors (6 mg/kg dehydroxymethylepoxyquinomicin twice a...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db12-1374

    authors: Kassan M,Choi SK,Galán M,Bishop A,Umezawa K,Trebak M,Belmadani S,Matrougui K

    更新日期:2013-06-01 00:00:00